NEW YORK, June 28 (GenomeWeb News) - Shares of Qiagen, Affymetrix, Invitrogen, Molecular Devices, Serologicals, and Sigma-Aldrich will be listed on the Nasdaq Global Select Market when the exchange creates the market tier for a set of high-performing companies on July 1, according to the Nasdaq web site.
On Feb. 15 Nasdaq said it will rename its National Market to Nasdaq Global Market and create a Nasdaq Global Select Market with the highest initial listing standards of any exchange in the world.
Under the change, companies listed on the exchange will be classified under three listing tiers: Nasdaq Global Select Market, Nasdaq Global Market, and Nasdaq Capital Market. Nasdaq said it plans to launch indexes based on these new tiers.
The financial and liquidity requirements to be listed on the Global Select Market are available here.